Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
Journal: Lancet (London, England)
Published: September 30, 2025
Valve Underexpansion and Clinical Outcomes With ACURATE neo2: Findings From the ACURATE IDE Trial.
Journal: Journal of the American College of Cardiology
Published: April 11, 2025
ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial.
Journal: Lancet (London, England)
Published: December 08, 2024
Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
Journal: European heart journal
Published: March 27, 2024
30-Day Clinical Outcomes of a Self-Expanding Transcatheter Aortic Valve: The International PORTICO NG Study.
Journal: JACC. Cardiovascular interventions
Published: January 22, 2023
One-Year Results of the Portico Transcatheter Aortic Heart Valve Using the Next-Generation FlexNav Delivery System.
Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: July 27, 2022
Safety Profile of an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System.
Journal: JACC. Cardiovascular interventions
Published: June 10, 2020
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
Journal: Lancet (London, England)
Published: August 19, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026